Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes

Journal of Physiology

Volumn 587, Issue 13, 2009, Pages 3301-3315

  Niu, You Guo ^a   Evans, Rhys D ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHYLOMICRON; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID OXIDATION; GLUCOSE BLOOD LEVEL; GLUCOSE OXIDATION; HEART DISEASE; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE CONTRACTILITY DYSFUNCTION; HEART WEIGHT; HEART WORK; INSULIN RESISTANCE; LIPID STORAGE; LIPOPROTEIN METABOLISM; MALE; MITOCHONDRIAL RESPIRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; RAT; ZUCKER DIABETIC FATTY RAT; HEART MUSCLE METABOLISM; LIPID ANALYSIS; LIPID COMPOSITION;

ANIMALS; CHYLOMICRONS; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; GLUCOSE; LIPOPROTEINS; LIPOPROTEINS, VLDL; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; OBESITY; OXIDATION-REDUCTION; PERFUSION; RATS; RATS, ZUCKER; TRIGLYCERIDES;

EID: 67650373466     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2009.173542     Document Type: Article

References (52)

1. Aasum E, Belke DD, Severson DL, Riemersma RA, Cooper M, Andreassen M & Larsen TS (2002). Cardiac function and metabolism in Type 2 diabetic mice after treatment with BM 17. 0744, a novel PPAR-α activator. Am J Physiol Heart Circ Physiol 283, H949-H957.
2. Aasum E, Hafstad AD, Severson DL & Larsen TS (2003). Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes 52, 434-441.
3. An D & Rodrigues B (2006). Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 291, H1489-H1506.
4. Augustus AS, Buchanan J, Park TS, Hirata K, Noh HL, Sun J, Homma S, D'Armiento J, Abel ED & Goldberg IJ (2006). Loss of lipoprotein lipase-derived fatty acids leads to increased cardiac glucose metabolism and heart dysfunction. J Biol Chem 281, 8716-8723.
5. Augustus AS, Kako Y, Yagyu H & Goldberg IJ (2003). Routes of FA delivery to cardiac muscle: Modulation of lipoprotein lipolysis alters uptake of TG-derived FA. Am J Physiol Endocrinol Metab 284, E331-E339.
6. Belke DD, Larsen TS, Gibbs EM & Severson DL (2000). Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am J Physiol Endocrinol Metab 279, E1104-E1113.
7. Belke DD, Larsen TS & Severson DL (2001). Cardiac function in perfused hearts from diabetic mice. Adv Exp Med Biol 498, 241-245.
8. Bennett MJ, Hauton D, Hole DG & Evans RD (2000a). Preparation of radiolabelled very-low-density lipoprotein in high yield by extended rat liver perfusion. Biotechnol Lett 22, 301-306.
9. Bennett MJ, Hauton D, Hole DG & Evans RD (2000b). Utilization of very low density lipoprotein by rat heart: The effect of endotoxin. Am J Physiol Endocrinol Metab 278, E802-E810.
10. Bezman-Tarcher A, Otway S & Robinson DS (1965). The removal of triglyceride fatty acids from incubation of the supradiaphragmatic portion of the rat. Proc R Soc Lond B Biol Sci 162, 411-426.
11. Carley AN, Semeniuk LM, Shimoni Y, Aasum E, Larsen TS, Berger JP & Severson DL (2004). Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function. Am J Physiol Endocrinol Metab 286, E449-E455.
12. Carley AN & Severson DL (2005). Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta 1734, 112-126.
13. Chatham JC & Seymour AM (2002). Cardiac carbohydrate metabolism in Zucker diabetic fatty rats. Cardiovasc Res 55, 104-112.
14. Chen D & Wang MW (2005). Development and application of rodent models for type 2 diabetes. Diabetes Obes Metab 7, 307-317.
15. Elovson J, Chatterton JE, Bell GT, Schumaker VN, Reuben MA, Puppione DL, Reeve JR Jr & Young NL (1988). Plasma very low density lipoproteins contain a single molecule of apolipoprotein B. J Lipid Res 29, 1461-1473.
16. Goldberg IJ (1996). Lipoprotein lipase and lipolysis: Central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 37, 693-707.
17. Golfman LS, Wilson CR, Sharma S, Burgmaier M, Young ME, Guthrie PH, Van Arsdall M, Adrogue JV, Brown KK & Taegtmeyer H (2005). Activation of PPARγ enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats. Am J Physiol Endocrinol Metab 289, E328-E336.
18. Hauton D, Bennett MJ & Evans RD (2001). Utilisation of triacylglycerol and non-esterified fatty acid by the working rat heart: myocardial lipid substrate preference. Biochim Biophys Acta 1533, 99-109.
19. How OJ, Aasum E, Severson DL, Chan WY, Essop MF & Larsen TS (2006). Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes 55, 466-473.
20. Howard BV (1994). Lipoprotein metabolism in diabetes. Curr Opin Lipidol 5, 216-220.
21. Irwin D, O'Looney PA, Quinet E & Vahouny GV (1984). Application of SDS gradient polyacrylamide slab gel electrophoresis to analysis of apolipoprotein mass and radioactivity of rat lipoproteins. Atherosclerosis 53, 163-172.
22. Kalogeris TJ & Story JA (1992). Lymph chylomicron composition and size are modified by level of intestinally infused cholesterol and triglyceride source in rats. J Nutr 122, 1045-1055.
23. Kamataki A, Takahashi S, Masamura K, Iwasaki T, Hattori H, Naiki H, Yamada K, Suzuki J, Miyamori I, Sakai J, Fujino T & Yamamoto TT (2002). Remnant lipoprotein particles are taken up into myocardium through VLDL receptor - a possible mechanism for cardiac fatty acid metabolism. Biochem Biophys Res Commun 293, 1007-1013.
24. Koishi R, Ando Y, Ono M, Shimamura M, Yasumo H, Fujiwara T, Horikoshi H & Furukawa H (2002). Angptl3 regulates lipid metabolism in mice. Nat Genet 30, 151-157.
25. Lewis GF & Steiner G (1996). Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 12, 37-56.
26. Liu L & Severson DL (1995). Myocardial lipoprotein lipase activity: regulation by diabetes and fructose-induced hypertriglyceridemia. Can J Physiol Pharmacol 73, 369-377.
27. Lopaschuk GD (1996). Abnormal mechanical function in diabetes: relationship to altered myocardial carbohydrate/lipid metabolism. Coron Artery Dis 7, 116-123.
28. Lopaschuk GD (2002). Metabolic abnormalities in the diabetic heart. Heart Fail Rev 7, 149-159.
29. McEneny J, O'Kane MJ, Moles KW, McMaster C, McMaster D, Mercer C, Trimble ER & Young IS (2000). Very low density lipoprotein subfractions in Type II diabetes mellitus: Alterations in composition and susceptibility to oxidation. Diabetologia 43, 485-493.
30. Mardy K, Belke DD & Severson DL (2001). Chylomicron metabolism by the isolated perfused mouse heart. Am J Physiol Endocrinol Metab 281, E357-E364.
31. Marsh SA, Powell PC, Agarwal A, Dell'Italia LJ & Chatham JC (2007). Cardiovascular dysfunction in Zucker obese and Zucker diabetic fatty rats: Role of hydronephrosis. Am J Physiol Heart Circ Physiol 293, H292-H298.
32. Neitzel AS, Carley AN & Severson DL (2003). Chylomicron and palmitate metabolism by perfused hearts from diabetic mice. Am J Physiol Endocrinol Metab 284, E357-E365.
33. Niu YG, Hauton D & Evans RD (2004). Utilization of triacylglycerol-rich lipoproteins by the working rat heart: Routes of uptake and metabolic fates. J Physiol 558, 225-237.
34. Paulson DJ & Crass MF 3rd (1982). Endogenous triacylglycerol metabolism in diabetic heart. Am J Physiol Heart Circ Physiol 242, H1084-H1094.
35. Rodrigues B & Severson DL (1993). Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats. Can J Physiol Pharmacol 71, 657-661.
36. Sambandam N, Abrahani MA, St Pierre E, Al-Atar O, Cam MC & Rodrigues B (1999). Localization of lipoprotein lipase in the diabetic heart: regulation by acute changes in insulin. Arterioscler Thromb Vasc Biol 19, 1526-1534.
37. Scanu AM & Edelstein C (1971). Solubility in aqueous solutions of ethanol of the small molecular weight peptides of the serum very low density and high density lipoproteins: Relevance to the recovery problem during delipidation of serum lipoproteins. Anal Biochem 44, 576-588.
38. Severson DL (2004). Diabetic cardiomyopathy: Recent evidence from mouse models of type 1 and type 2 diabetes. Can J Physiol Pharmacol 82, 813-823.
39. Steiner G, Tkac I, Uffelman KD & Lewis GF (1998). Important contribution of lipoprotein particle number to plasma triglyceride concentration in type 2 diabetes. Atherosclerosis 137, 211-214.
40. Taegtmeyer H, Hems R & Krebs HA (1980). Utilization of energy-providing substrates in the isolated working rat heart. Biochem J 186, 701-711.
41. Taskinen MR (1987). Lipoprotein lipase in diabetes. Diabetes Metab Rev 3, 551-570.
42. Tavangar K, Murata Y, Pedersen ME, Goers JF, Hoffman AR & Kraemer FB (1992). Regulation of lipoprotein lipase in the diabetic rat. J Clin Invest 90, 1672-1678.
43. Teusink B, Voshol PJ, Dahlmans VE, Rensen PC, Pijl H, Romijn JA & Havekes LM (2003). Contribution of fatty acids released from lipolysis of plasma triglycerides to total plasma fatty acid flux and tissue-specific fatty acid uptake. Diabetes 52, 614-620.
44. Tomkin GH & Owens D (2001). Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis. Diabetes Metab Res Rev 17, 27-43.
45. Unger RH & Orci L (2002). Lipoapoptosis: Its mechanism and its diseases. Biochim Biophys Acta 1585, 202-212.
46. Van Der Vusse GJ, van Bilsen M & Glatz JF (2000). Cardiac fatty acid uptake and transport in health and disease. Cardiovasc Res 45, 279-293.
47. Vincent G, Bouchard B, Khairallah M & Des Rosiers C (2004). Differential modulation of citrate synthesis and release by fatty acids in perfused working rat hearts. Am J Physiol Heart Circ Physiol 286, H257-H266.
48. Wang P & Chatham JC (2004). Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart. Am J Physiol Endocrinol Metab 286, E725-E736.
49. Wang P, Lloyd SG, Zeng H, Bonen A & Chatham JC (2005). Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol 288, H2102-H2110.
50. Young ME, Guthrie PH, Razeghi P, Leighton B, Abbasi S, Patil S, Youker KA & Taegtmeyer H (2002a). Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Diabetes 51, 2587-2595.
51. Young ME, McNulty P & Taegtmeyer H (2002b). Adaptation and malPdaptation of the heart in diabetes: Part II: potential mechanisms. Circulation 105, 1861-1870.
52. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L & Unger RH (2000). Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A 97, 1784-1789.